There is a connection between fluoroquinolone antibiotics (FLQ) and peripheral neuropathy, a terrible form of nerve damage. In addition, our firm is seeking people who took FLQ antibiotics before suffering an aortic aneurysm or aortic dissection. Recent studies have shown that taking fluoroquinolones, like Avelox, Levaquin or Cipro can double a patient’s risk for peripheral neuropathy, and exponentially increase the risk of aortic injuries including aortic aneurysm, dissection, and rupture.
Potentially fatal aortic valve ruptures and aneurysms are not acceptable side effects, and both patients and doctors prescribing FLQ drugs were not told about them. Antibiotic nerve damage is also inexcusable, and drug manufacturers need to be held accountable for the severe pain thousands of patients are suffering from after taking what they though was a safe drug.
Common side effects reported by the manufacturers of flq drugs include:
The side effects disclosed by manufacturers above did not mention any of the serious and potentially deadly side effects that the CDC only recently started warning consumers about. In November of 2015, the Journal of American Medicine published the findings of a study assessing the link between aortic injuries and the use of FLQ antibiotics. According to the study, people who take fluoroquinolone are twice as likely to have an aortic aneurysm, dissection or rupture. It also reported the increased risk of peripheral neuropathy, tendonitis, and nerve damage among people who have taken fluoroquinolone in the last 60 days.
Unfortunately we do not know the scope of the coverup involved by the manufacturing companies, but the studies conducted by Journal of American Medicine and other subsequent studies quickly indicated that these dangerous side effects were easy to spot, and should have been reported by the manufacturers. Some of the dangerous side effects we now know about and that you could be eligible to get a payout for include:
Fluoroquinolone is a powerful type of broad spectrum antibiotic drug used to treat bacterial infections, antibiotic resistant infections, and hospital acquired infections. Common hospital acquired infections treated with fluoroquinolone drugs include: hospital acquired pneumonia (nosocomial pneumonia), staph infections, methicillin-resistant S aureus (MRSA) Klebsiella pneumonia, blood stream infections, and urinary tract infections. Fluoroquinolone antibiotics are commonly used in the United States, but in UK for example, they are highly restricted except for the treatment of patients with cystic fibrosis or Anthrax. Only recently has the CDC issued a warning about the unreported side effects that could seriously injure, disable, or kill people taking them.
